Membership
Tour
Register
Log in
HETEROCYCLIC COMPOUNDS
Follow
Industry
CPC
C07D
Parent Industries
C
CHEMISTRY METALLURGY
C07
Organic chemistry
Current Industry
C07D
HETEROCYCLIC COMPOUNDS
Sub Industries
C07D201/00
Preparation, separation, purification or stabilisation of unsubstituted lactams
C07D203/00
Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
C07D205/00
Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
C07D207/00
Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
C07D209/00
Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
C07D211/00
Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
C07D213/00
Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
C07D215/00
Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
C07D217/00
Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
C07D219/00
Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
C07D221/00
Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
C07D223/00
Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
C07D225/00
Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
C07D227/00
Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00
C07D229/00
Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms
C07D231/00
Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
C07D233/00
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
C07D235/00
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
C07D237/00
Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
C07D239/00
Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
C07D241/00
Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
C07D243/00
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
C07D245/00
Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
C07D247/00
Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups C07D229/00 - C07D245/00
C07D249/00
Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
C07D251/00
Heterocyclic compounds containing 1,3,5-triazine rings
C07D253/00
Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
C07D255/00
Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
C07D257/00
Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
C07D259/00
Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
C07D261/00
Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
C07D263/00
Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
C07D265/00
Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
C07D267/00
Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
C07D269/00
Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups C07D261/00 - C07D267/00
C07D271/00
Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
C07D273/00
Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
C07D275/00
Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
C07D277/00
Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
C07D279/00
Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
C07D281/00
Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
C07D283/00
Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups C07D275/00 - C07D281/00
C07D285/00
Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
C07D291/00
Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
C07D293/00
Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
C07D295/00
Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicylo [3.2.2.] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
C07D301/00
Preparation of oxiranes
C07D303/00
Compounds containing three-membered rings having one oxygen atom as the only ring heteroatom
C07D305/00
Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atom
C07D307/00
Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
C07D309/00
Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
C07D311/00
Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
C07D313/00
Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
C07D315/00
Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups C07D303/00 - C07D313/00
C07D317/00
Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
C07D319/00
Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
C07D321/00
Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
C07D323/00
Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
C07D325/00
Heterocyclic compounds containing rings having oxygen as the only ring hetero atoms according to more than one of the main groups C07D303/00 - C07D323/00
C07D327/00
Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
C07D329/00
Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms
C07D331/00
Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
C07D333/00
Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
C07D335/00
Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
C07D337/00
Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
C07D339/00
Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
C07D341/00
Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms
C07D343/00
Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms
C07D345/00
Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms
C07D347/00
Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms
C07D401/00
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
C07D403/00
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
C07D405/00
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
C07D407/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
C07D409/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
C07D411/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
C07D413/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
C07D415/00
Heterocyclic compounds containing the thiamine skeleton
C07D417/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
C07D419/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
C07D421/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms
C07D451/00
Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems
C07D453/00
Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems
C07D455/00
Heterocyclic compounds containing quinolizine ring systems
C07D457/00
Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems
C07D459/00
Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems
C07D461/00
Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems
C07D463/00
Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:
C07D471/00
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
C07D473/00
Heterocyclic compounds containing purine ring systems
C07D475/00
Heterocyclic compounds containing pteridine ring systems
C07D477/00
Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , carbapenicillins, thienamycins Such ring systems being further condensed
C07D487/00
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
C07D489/00
Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems
C07D491/00
Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
C07D493/00
Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
C07D495/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
C07D497/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
C07D498/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
C07D499/00
Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:
C07D501/00
Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:
C07D503/00
Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:
C07D505/00
Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:
C07D507/00
Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups C07D463/00, C07D477/00 or C07D499/00 - C07D505/00 Such ring systems being further condensed
C07D513/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
C07D515/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
C07D517/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium or halogen atoms as ring hetero atoms
C07D519/00
Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
C07D521/00
Heterocyclic compounds containing unspecified hetero rings
Industries
Overview
Organizations
People
Information
Impact
Please log in for detailed analytics
Patents Grants
last 30 patents
Information
Patent Grant
Inhibitory material against human body-derived nicotinamide adenine...
Patent number
12,221,426
Issue date
Feb 11, 2025
Seoul National University R&DBFoundation
Bong-Jin Lee
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Heterocyclic compound
Patent number
12,221,431
Issue date
Feb 11, 2025
Sumitomo Chemical Company, Limited
Takamasa Tanabe
A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information
Patent Grant
Estrogen receptor antagonist
Patent number
12,221,432
Issue date
Feb 11, 2025
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Shuwen Duan
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Crystalline forms of diazabicyclooctane derivative and production p...
Patent number
12,221,443
Issue date
Feb 11, 2025
Meiji Seika Pharma Co., Ltd.
Takao Abe
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Diorganyl diselenide-clubbed quaternary purines as corrosion inhibi...
Patent number
12,221,451
Issue date
Feb 11, 2025
KING FAISAL UNIVERSITY
Saadeldin Elsayed Ibrahim Shabaan
C23 - COATING METALLIC MATERIAL COATING MATERIAL WITH METALLIC MATERIAL CHEMI...
Information
Patent Grant
Method for producing halogenated zinc phthalocyanine pigment
Patent number
12,221,546
Issue date
Feb 11, 2025
DIC Corporation
Keisuke Sakamoto
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Composition for organic optoelectronic device, organic optoelectron...
Patent number
12,225,815
Issue date
Feb 11, 2025
Samsung SDI Co., Ltd.
Dong Wan Ryu
C09 - DYES PAINTS POLISHES NATURAL RESINS ADHESIVES MISCELLANEOUS COMPOSITION...
Information
Patent Grant
Compounds useful as kinase inhibitors
Patent number
12,220,401
Issue date
Feb 11, 2025
Loxo Oncology, Inc.
Nicolas Guisot
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Method for preparing chiral alkyl compounds by asymmetric hydrogena...
Patent number
12,221,409
Issue date
Feb 11, 2025
Zhejiang University
Zhan Lu
B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information
Patent Grant
Processes to produce brivaracetam
Patent number
12,221,413
Issue date
Feb 11, 2025
SUZHOU PENGXU PHARMATECH CO. LTD.
Peng Wang
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Method for synthesizing 1,3,2-dioxathiolane 2,2-dioxide by in-situ...
Patent number
12,221,429
Issue date
Feb 11, 2025
SHANDONG NORMAL UNIVERSITY
Qikui Liu
B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information
Patent Grant
Compound having pyrimidine ring structure and organic electrolumine...
Patent number
12,221,430
Issue date
Feb 11, 2025
Hodogaya Chemical Co., Ltd.
Kouki Kase
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Plasma kallikrein inhibitors and uses thereof
Patent number
12,221,441
Issue date
Feb 11, 2025
Takeda Pharmaceutical Company Limited
Nikolaos Papaioannou
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and amino e...
Patent number
12,221,445
Issue date
Feb 11, 2025
Merck Patent GmbH
Rudolf Moser
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleu...
Patent number
12,221,446
Issue date
Feb 11, 2025
Rudolf Moser
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Methods and compositions for drugs to treat ophthalmic diseases
Patent number
12,221,447
Issue date
Feb 11, 2025
Duke University
Scott W. Cousins
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Synthesis of cantharidin
Patent number
12,221,452
Issue date
Feb 11, 2025
Verrica Pharmaceuticals Inc.
Matthew Gene Davidson
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Condensed cyclic compound and organic light-emitting device includi...
Patent number
12,225,817
Issue date
Feb 11, 2025
Samsung Electronics Co., Ltd.
Sangmo Kim
C09 - DYES PAINTS POLISHES NATURAL RESINS ADHESIVES MISCELLANEOUS COMPOSITION...
Information
Patent Grant
BCL-2 inhibitors
Patent number
12,220,419
Issue date
Feb 11, 2025
Newave Pharmaceutical Inc.
Yi Chen
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Quaternary ammonium salt compound, preparation method therefor and...
Patent number
12,221,414
Issue date
Feb 11, 2025
West China Hospital, Sichuan University
Bowen Ke
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Montelukast berberine quaternary ammonium salt compound and double...
Patent number
12,221,418
Issue date
Feb 11, 2025
EYE HOSPITAL, WENZHOU MEDICAL UNIVERSITY
Wei Chen
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Process for synthesis of Fipronil
Patent number
12,221,421
Issue date
Feb 11, 2025
Gharda Chemicals Limited
Keki Hormusji Gharda
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Compounds and their use for the treatment of alpha1-antitrypsin def...
Patent number
12,221,422
Issue date
Feb 11, 2025
CENTESSA PHARMACEUTICALS (UK) LIMITED
Nigel Ramsden
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Organic molecules, in particular for use in optoelectronic devices
Patent number
12,221,435
Issue date
Feb 11, 2025
Samsung Display Co., Ltd.
Stefan Seifermann
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Selective PI3Kδ inhibitor and use thereof
Patent number
12,221,448
Issue date
Feb 11, 2025
Tarapeutics Science Inc.
Qingsong Liu
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Pyrrolopyrimidine derivative and use thereof
Patent number
12,221,449
Issue date
Feb 11, 2025
WUHAN HUMANWELL INNOVATIVE DRUG RESEARCH AND DEVELOPMENT CENTER LIMITED COMPANY
Xuejun Zhang
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
5-(substitutedphenyl)-7-thioxo-7,8-dihydropyrimido[4,5-d]pyrimidine...
Patent number
12,221,450
Issue date
Feb 11, 2025
KING FAISAL UNIVERSITY
Katharigatta N. Venugopala
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Organic compound and organic electroluminescent device comprising t...
Patent number
12,225,813
Issue date
Feb 11, 2025
DOOSAN SOLUS CO., LTD.
Hyung Chan Bae
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Highly loaded metal oxide materials by self-assembly for extended b...
Patent number
12,220,467
Issue date
Feb 11, 2025
MESOSIL INC.
Cameron Alexander Stewart
A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information
Patent Grant
Compounds as NLRP3 inflammasome inhibitors and compositions and use...
Patent number
12,221,406
Issue date
Feb 11, 2025
Virginia Commonwealth University
Shijun Zhang
C07 - ORGANIC CHEMISTRY
Patents Applications
last 30 patents
Information
Patent Application
SYNTHESIS OF ESTER, CARBONATE, AND CARBAMATE-DERIVED NOVEL BIODEGRA...
Publication number
20250049714
Publication date
Feb 13, 2025
Massachusetts Institute of Technology
Daniel Griffith Anderson
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Application
SMALL MOLECULE TRACER FOR IMAGING ALPHA-SYNUCLEIN AGGREGATES
Publication number
20250049966
Publication date
Feb 13, 2025
Fudan University
Yong CHU
C07 - ORGANIC CHEMISTRY
Information
Patent Application
BICYCLO [3.2.0] HEPTANE BIS(AMIDE) RXFP1 AGONISTS
Publication number
20250049765
Publication date
Feb 13, 2025
Bristol-Myers Squibb Company
Andrew K. Dilger
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES
Publication number
20250049772
Publication date
Feb 13, 2025
Takeda Pharmaceutical Company Limited
Zacharia Cheruvallath
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF, IN PARTICULAR FOR A...
Publication number
20250049776
Publication date
Feb 13, 2025
Samsara Therapeutics Inc.
Peter Hamley
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
Synthesis of MEK7 Inhibitors and methods of Use Thereof
Publication number
20250049791
Publication date
Feb 13, 2025
Northwestern University
Karl A. Scheidt
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
SACUBITRIL INTERMEDIATE, PREPARATION METHOD THEREFOR, AND USE THEREOF
Publication number
20250051270
Publication date
Feb 13, 2025
SHENZHEN CATALYS TECHNOLOGY CO., LTD.
Qiwei LANG
C07 - ORGANIC CHEMISTRY
Information
Patent Application
PYRROLE DERIVATIVE OR PHARMACEUTICALLY OR SITOLOGICALLY ACCEPTABLE...
Publication number
20250051275
Publication date
Feb 13, 2025
HANA PHARM CO., LTD.
Jae Ho YOO
C07 - ORGANIC CHEMISTRY
Information
Patent Application
DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS
Publication number
20250051277
Publication date
Feb 13, 2025
Sensorium Therapeutics, Inc.
Jacob M. Hooker
C07 - ORGANIC CHEMISTRY
Information
Patent Application
SMALL MOLECULE INHIBITORS OF PR3 AND HNE AND USES THEREOF
Publication number
20250051286
Publication date
Feb 13, 2025
ORIXA THERAPEUTICS LLC
Adam Seth HAEBERLE
C07 - ORGANIC CHEMISTRY
Information
Patent Application
TRAINING AN UNSUPERVISED MEMORY-BASED PREDICTION SYSTEM TO LEARN CO...
Publication number
20250051289
Publication date
Feb 13, 2025
DeepMind Technologies Limited
Gregory Duncan Wayne
C07 - ORGANIC CHEMISTRY
Information
Patent Application
NOVEL OXADIAZOLE DERIVATIVE AND USE THEREOF
Publication number
20250051293
Publication date
Feb 13, 2025
Celros Biotech
Yun Soo Bae
C07 - ORGANIC CHEMISTRY
Information
Patent Application
MODULATORS OF MYOCYTE LIPID ACCUMULATION AND INSULIN RESISTANCE AND...
Publication number
20250051296
Publication date
Feb 13, 2025
The Trustees of the University of Pennsylvania
Daniel Kelly
C07 - ORGANIC CHEMISTRY
Information
Patent Application
CONTINUOUS FLOW CHEMISTRY FOR SYNTHESIS OF CANNABINOIDS
Publication number
20250051298
Publication date
Feb 13, 2025
COLORADO CHROMATOGRAPHY, LLC
Giovanni A. RAMIREZ
B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information
Patent Application
BETA-CATENIN AND B-CELL LYMPHOMA 9 (BCL9) INHIBITORS
Publication number
20250051304
Publication date
Feb 13, 2025
H. Lee Moffitt Cancer Center & Research Institute, Inc.
Haitao JI
C07 - ORGANIC CHEMISTRY
Information
Patent Application
NITROGEN-CONTAINING SATURATED HETEROCYCLYL DERIVATIVE
Publication number
20250051305
Publication date
Feb 13, 2025
Sumitomo Pharma Co., Ltd.
Hitoshi WATANABE
C07 - ORGANIC CHEMISTRY
Information
Patent Application
Process for Manufacturing Pibrentasvir Active Drug Substance
Publication number
20250051312
Publication date
Feb 13, 2025
ABBVIE INC.
Michael Hillier
C07 - ORGANIC CHEMISTRY
Information
Patent Application
TRICYCLIC DERIVATIVE AND PREPARATION METHOD THEREFOR AND APPLICATIO...
Publication number
20250051321
Publication date
Feb 13, 2025
Shanghai Jemincare Pharmaceutical Co., Ltd.
Gang DENG
C07 - ORGANIC CHEMISTRY
Information
Patent Application
MALT-1 MODULATORS
Publication number
20250051327
Publication date
Feb 13, 2025
EXSCIENTIA AI LIMITED
Peter Ray
C07 - ORGANIC CHEMISTRY
Information
Patent Application
POLYMORPH OF KRAS INHIBITOR, PREPARATION METHOD THEREFOR, AND USE T...
Publication number
20250051333
Publication date
Feb 13, 2025
GENFLEET THERAPEUTICS (SHANGHAI) INC.
Fusheng ZHOU
C07 - ORGANIC CHEMISTRY
Information
Patent Application
PYRIDINE-3-CARBOXYLATE COMPOUNDS AS CAV1.2 ACTIVATORS
Publication number
20250051345
Publication date
Feb 13, 2025
Novartis AG
Simon Krautwald
C07 - ORGANIC CHEMISTRY
Information
Patent Application
NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC A...
Publication number
20250051349
Publication date
Feb 13, 2025
Idemitsu Kosan Co., Ltd.
Yuki NAKANO
C07 - ORGANIC CHEMISTRY
Information
Patent Application
COMPOUNDS, COMPOSITIONS, AND METHODS
Publication number
20250051355
Publication date
Feb 13, 2025
ACONCAGUA BIO, INC.
Hui LEI
C07 - ORGANIC CHEMISTRY
Information
Patent Application
ELECTRO-OPTIC FILM, COMPOUND, ELECTRO-OPTIC COMPOSITION, AND ELECTR...
Publication number
20250053030
Publication date
Feb 13, 2025
SUMITOMO CHEMICAL COMPANY, LIMITED
Eiji YOSHIKAWA
C07 - ORGANIC CHEMISTRY
Information
Patent Application
FLUOROGENIC CYANINE COMPOUNDS FOR DETECTING NUCLEIC ACIDS
Publication number
20250052650
Publication date
Feb 13, 2025
AAT Bioquest, Inc.
Zhenjun DIWU
C09 - DYES PAINTS POLISHES NATURAL RESINS ADHESIVES MISCELLANEOUS COMPOSITION...
Information
Patent Application
ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND PATTERN FO...
Publication number
20250053087
Publication date
Feb 13, 2025
Shin-Etsu Chemical Co., Ltd.
Masahiro Fukushima
C07 - ORGANIC CHEMISTRY
Information
Patent Application
SECONDARY BATTERY, AND BATTERY MODULE, BATTERY PACK, AND ELECTRICAL...
Publication number
20250054963
Publication date
Feb 13, 2025
CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED
Limei Zhang
H01 - BASIC ELECTRIC ELEMENTS
Information
Patent Application
DIARYLOXYBENZOHETERODIAZOLE COMPOUNDS DISUBSTITUTED WITH THIENOTHIO...
Publication number
20250051352
Publication date
Feb 13, 2025
ENI S.p.A.
Luigi ABBONDANZA
C07 - ORGANIC CHEMISTRY
Information
Patent Application
SOLID FORMS OF A GPR119 AGONIST AND PROCESSES FOR THE PREPARATION T...
Publication number
20250051357
Publication date
Feb 13, 2025
Mankind Pharma Ltd.
Sazid ALI
C07 - ORGANIC CHEMISTRY
Information
Patent Application
5,6,7,8-TETRAHYDRO-2,6-NAPHTHYRIDINE DERIVATIVES AS CANCER THERAPEU...
Publication number
20250051361
Publication date
Feb 13, 2025
VRise Therapeutics, Inc.
Prashant Kashinath BHAVAR
C07 - ORGANIC CHEMISTRY